nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—Hypotensive—Betamethasone—multiple sclerosis	0.017	0.0254	CcSEcCtD
Phentolamine—Hypotensive—Dexamethasone—multiple sclerosis	0.017	0.0254	CcSEcCtD
Phentolamine—Injection site reaction—Cladribine—multiple sclerosis	0.0137	0.0205	CcSEcCtD
Phentolamine—Bradycardia—Fingolimod—multiple sclerosis	0.0125	0.0186	CcSEcCtD
Phentolamine—Cardiac disorder—Fingolimod—multiple sclerosis	0.0114	0.017	CcSEcCtD
Phentolamine—Peptic ulcer—Prednisolone—multiple sclerosis	0.0111	0.0166	CcSEcCtD
Phentolamine—Angiopathy—Fingolimod—multiple sclerosis	0.0111	0.0166	CcSEcCtD
Phentolamine—Mediastinal disorder—Fingolimod—multiple sclerosis	0.011	0.0165	CcSEcCtD
Phentolamine—Peptic ulcer—Triamcinolone—multiple sclerosis	0.0102	0.0153	CcSEcCtD
Phentolamine—Peptic ulcer—Methylprednisolone—multiple sclerosis	0.0102	0.0153	CcSEcCtD
Phentolamine—Peptic ulcer—Betamethasone—multiple sclerosis	0.0093	0.0139	CcSEcCtD
Phentolamine—Peptic ulcer—Dexamethasone—multiple sclerosis	0.0093	0.0139	CcSEcCtD
Phentolamine—ADRA2A—peripheral nervous system—multiple sclerosis	0.00923	0.0865	CbGeAlD
Phentolamine—Hypertension—Fingolimod—multiple sclerosis	0.0092	0.0137	CcSEcCtD
Phentolamine—Nervous system disorder—Fingolimod—multiple sclerosis	0.00853	0.0127	CcSEcCtD
Phentolamine—Hypotension—Fingolimod—multiple sclerosis	0.00812	0.0121	CcSEcCtD
Phentolamine—Peptic ulcer—Prednisone—multiple sclerosis	0.0081	0.0121	CcSEcCtD
Phentolamine—Paraesthesia—Fingolimod—multiple sclerosis	0.00781	0.0117	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00751	0.0112	CcSEcCtD
Phentolamine—Cardiac disorder—Cladribine—multiple sclerosis	0.00644	0.00961	CcSEcCtD
Phentolamine—Angiopathy—Cladribine—multiple sclerosis	0.00629	0.0094	CcSEcCtD
Phentolamine—Mediastinal disorder—Cladribine—multiple sclerosis	0.00625	0.00934	CcSEcCtD
Phentolamine—Asthenia—Fingolimod—multiple sclerosis	0.00624	0.00932	CcSEcCtD
Phentolamine—Arrhythmia—Cladribine—multiple sclerosis	0.0062	0.00925	CcSEcCtD
Phentolamine—Pruritus—Fingolimod—multiple sclerosis	0.00615	0.00919	CcSEcCtD
Phentolamine—Abdominal pain upper—Mitoxantrone—multiple sclerosis	0.00602	0.00899	CcSEcCtD
Phentolamine—Diarrhoea—Fingolimod—multiple sclerosis	0.00595	0.00888	CcSEcCtD
Phentolamine—NISCH—medulla oblongata—multiple sclerosis	0.00591	0.0554	CbGeAlD
Phentolamine—Dizziness—Fingolimod—multiple sclerosis	0.00575	0.00859	CcSEcCtD
Phentolamine—Headache—Fingolimod—multiple sclerosis	0.00545	0.00813	CcSEcCtD
Phentolamine—NISCH—midbrain—multiple sclerosis	0.0054	0.0506	CbGeAlD
Phentolamine—NISCH—spinal cord—multiple sclerosis	0.00527	0.0494	CbGeAlD
Phentolamine—Chest pain—Cladribine—multiple sclerosis	0.00514	0.00768	CcSEcCtD
Phentolamine—Mediastinal disorder—Azathioprine—multiple sclerosis	0.00508	0.00759	CcSEcCtD
Phentolamine—Arrhythmia—Azathioprine—multiple sclerosis	0.00504	0.00752	CcSEcCtD
Phentolamine—Acute coronary syndrome—Mitoxantrone—multiple sclerosis	0.00501	0.00748	CcSEcCtD
Phentolamine—Myocardial infarction—Mitoxantrone—multiple sclerosis	0.00498	0.00744	CcSEcCtD
Phentolamine—Nervous system disorder—Cladribine—multiple sclerosis	0.00483	0.00722	CcSEcCtD
Phentolamine—Tachycardia—Cladribine—multiple sclerosis	0.00481	0.00718	CcSEcCtD
Phentolamine—Bradycardia—Mitoxantrone—multiple sclerosis	0.00464	0.00693	CcSEcCtD
Phentolamine—Hypotension—Cladribine—multiple sclerosis	0.0046	0.00688	CcSEcCtD
Phentolamine—Paraesthesia—Cladribine—multiple sclerosis	0.00443	0.00661	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00425	0.00635	CcSEcCtD
Phentolamine—Pain—Cladribine—multiple sclerosis	0.00421	0.00629	CcSEcCtD
Phentolamine—NISCH—cerebellum—multiple sclerosis	0.00418	0.0391	CbGeAlD
Phentolamine—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.00411	0.00613	CcSEcCtD
Phentolamine—Myocardial infarction—Prednisolone—multiple sclerosis	0.00408	0.0061	CcSEcCtD
Phentolamine—Arrhythmia—Mitoxantrone—multiple sclerosis	0.00407	0.00608	CcSEcCtD
Phentolamine—ADRA1A—brainstem—multiple sclerosis	0.00406	0.0381	CbGeAlD
Phentolamine—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00403	0.00602	CcSEcCtD
Phentolamine—Abdominal pain—Cladribine—multiple sclerosis	0.0039	0.00582	CcSEcCtD
Phentolamine—Bradycardia—Prednisolone—multiple sclerosis	0.00381	0.00569	CcSEcCtD
Phentolamine—ADRA1B—nervous system—multiple sclerosis	0.00379	0.0355	CbGeAlD
Phentolamine—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.00378	0.00564	CcSEcCtD
Phentolamine—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.00377	0.00563	CcSEcCtD
Phentolamine—Myocardial infarction—Triamcinolone—multiple sclerosis	0.00376	0.00561	CcSEcCtD
Phentolamine—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.00375	0.0056	CcSEcCtD
Phentolamine—Hypotension—Azathioprine—multiple sclerosis	0.00374	0.00559	CcSEcCtD
Phentolamine—ADRA1D—nervous system—multiple sclerosis	0.00371	0.0347	CbGeAlD
Phentolamine—ADRA1B—central nervous system—multiple sclerosis	0.00365	0.0342	CbGeAlD
Phentolamine—ADRA1D—central nervous system—multiple sclerosis	0.00357	0.0334	CbGeAlD
Phentolamine—Asthenia—Cladribine—multiple sclerosis	0.00354	0.00528	CcSEcCtD
Phentolamine—Bradycardia—Triamcinolone—multiple sclerosis	0.0035	0.00523	CcSEcCtD
Phentolamine—Bradycardia—Methylprednisolone—multiple sclerosis	0.00349	0.00522	CcSEcCtD
Phentolamine—Pruritus—Cladribine—multiple sclerosis	0.00349	0.00521	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00346	0.00517	CcSEcCtD
Phentolamine—SIGMAR1—medulla oblongata—multiple sclerosis	0.00344	0.0322	CbGeAlD
Phentolamine—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.00343	0.00512	CcSEcCtD
Phentolamine—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.00343	0.00512	CcSEcCtD
Phentolamine—Hypertension—Mitoxantrone—multiple sclerosis	0.00343	0.00512	CcSEcCtD
Phentolamine—Myocardial infarction—Dexamethasone—multiple sclerosis	0.00341	0.00509	CcSEcCtD
Phentolamine—Myocardial infarction—Betamethasone—multiple sclerosis	0.00341	0.00509	CcSEcCtD
Phentolamine—NISCH—brain—multiple sclerosis	0.00339	0.0318	CbGeAlD
Phentolamine—Chest pain—Mitoxantrone—multiple sclerosis	0.00338	0.00505	CcSEcCtD
Phentolamine—Diarrhoea—Cladribine—multiple sclerosis	0.00337	0.00504	CcSEcCtD
Phentolamine—Arrhythmia—Prednisolone—multiple sclerosis	0.00334	0.00499	CcSEcCtD
Phentolamine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00328	0.00489	CcSEcCtD
Phentolamine—Dizziness—Cladribine—multiple sclerosis	0.00326	0.00487	CcSEcCtD
Phentolamine—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.00319	0.00476	CcSEcCtD
Phentolamine—Bradycardia—Dexamethasone—multiple sclerosis	0.00318	0.00475	CcSEcCtD
Phentolamine—Bradycardia—Betamethasone—multiple sclerosis	0.00318	0.00475	CcSEcCtD
Phentolamine—Abdominal pain—Azathioprine—multiple sclerosis	0.00317	0.00473	CcSEcCtD
Phentolamine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00316	0.00472	CcSEcCtD
Phentolamine—SIGMAR1—midbrain—multiple sclerosis	0.00314	0.0294	CbGeAlD
Phentolamine—Vomiting—Cladribine—multiple sclerosis	0.00313	0.00468	CcSEcCtD
Phentolamine—Angiopathy—Methylprednisolone—multiple sclerosis	0.00311	0.00465	CcSEcCtD
Phentolamine—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.00309	0.00462	CcSEcCtD
Phentolamine—Headache—Cladribine—multiple sclerosis	0.00309	0.00461	CcSEcCtD
Phentolamine—Arrhythmia—Triamcinolone—multiple sclerosis	0.00307	0.00459	CcSEcCtD
Phentolamine—Arrhythmia—Methylprednisolone—multiple sclerosis	0.00307	0.00458	CcSEcCtD
Phentolamine—SIGMAR1—spinal cord—multiple sclerosis	0.00306	0.0287	CbGeAlD
Phentolamine—Hypotension—Mitoxantrone—multiple sclerosis	0.00303	0.00452	CcSEcCtD
Phentolamine—Acute coronary syndrome—Prednisone—multiple sclerosis	0.00298	0.00446	CcSEcCtD
Phentolamine—Myocardial infarction—Prednisone—multiple sclerosis	0.00297	0.00443	CcSEcCtD
Phentolamine—Nausea—Cladribine—multiple sclerosis	0.00293	0.00437	CcSEcCtD
Phentolamine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00291	0.00434	CcSEcCtD
Phentolamine—ADRA1B—brain—multiple sclerosis	0.0029	0.0271	CbGeAlD
Phentolamine—ADRA1D—brain—multiple sclerosis	0.00283	0.0265	CbGeAlD
Phentolamine—Angiopathy—Betamethasone—multiple sclerosis	0.00283	0.00423	CcSEcCtD
Phentolamine—Angiopathy—Dexamethasone—multiple sclerosis	0.00283	0.00423	CcSEcCtD
Phentolamine—Hypertension—Prednisolone—multiple sclerosis	0.00281	0.0042	CcSEcCtD
Phentolamine—Arrhythmia—Betamethasone—multiple sclerosis	0.00279	0.00416	CcSEcCtD
Phentolamine—Arrhythmia—Dexamethasone—multiple sclerosis	0.00279	0.00416	CcSEcCtD
Phentolamine—Pain—Mitoxantrone—multiple sclerosis	0.00277	0.00414	CcSEcCtD
Phentolamine—Bradycardia—Prednisone—multiple sclerosis	0.00277	0.00413	CcSEcCtD
Phentolamine—Diarrhoea—Azathioprine—multiple sclerosis	0.00274	0.00409	CcSEcCtD
Phentolamine—ADRA2C—medulla oblongata—multiple sclerosis	0.0027	0.0253	CbGeAlD
Phentolamine—Dizziness—Azathioprine—multiple sclerosis	0.00265	0.00396	CcSEcCtD
Phentolamine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00265	0.00396	CcSEcCtD
Phentolamine—Tachycardia—Prednisolone—multiple sclerosis	0.00259	0.00387	CcSEcCtD
Phentolamine—Hypertension—Triamcinolone—multiple sclerosis	0.00259	0.00386	CcSEcCtD
Phentolamine—Hypertension—Methylprednisolone—multiple sclerosis	0.00258	0.00385	CcSEcCtD
Phentolamine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00256	0.00382	CcSEcCtD
Phentolamine—Vomiting—Azathioprine—multiple sclerosis	0.00255	0.0038	CcSEcCtD
Phentolamine—Flushing—Prednisone—multiple sclerosis	0.00252	0.00377	CcSEcCtD
Phentolamine—Headache—Azathioprine—multiple sclerosis	0.00251	0.00375	CcSEcCtD
Phentolamine—ADRA2C—midbrain—multiple sclerosis	0.00247	0.0231	CbGeAlD
Phentolamine—Angiopathy—Prednisone—multiple sclerosis	0.00247	0.00368	CcSEcCtD
Phentolamine—SIGMAR1—cerebellum—multiple sclerosis	0.00243	0.0228	CbGeAlD
Phentolamine—Arrhythmia—Prednisone—multiple sclerosis	0.00243	0.00363	CcSEcCtD
Phentolamine—ADRA2C—spinal cord—multiple sclerosis	0.00241	0.0226	CbGeAlD
Phentolamine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00239	0.00357	CcSEcCtD
Phentolamine—Paraesthesia—Prednisolone—multiple sclerosis	0.00239	0.00356	CcSEcCtD
Phentolamine—Tachycardia—Triamcinolone—multiple sclerosis	0.00239	0.00356	CcSEcCtD
Phentolamine—Nausea—Azathioprine—multiple sclerosis	0.00238	0.00355	CcSEcCtD
Phentolamine—Tachycardia—Methylprednisolone—multiple sclerosis	0.00238	0.00355	CcSEcCtD
Phentolamine—Hypertension—Betamethasone—multiple sclerosis	0.00235	0.0035	CcSEcCtD
Phentolamine—Hypertension—Dexamethasone—multiple sclerosis	0.00235	0.0035	CcSEcCtD
Phentolamine—Asthenia—Mitoxantrone—multiple sclerosis	0.00232	0.00347	CcSEcCtD
Phentolamine—Hypotension—Methylprednisolone—multiple sclerosis	0.00228	0.0034	CcSEcCtD
Phentolamine—Pain—Prednisolone—multiple sclerosis	0.00227	0.00339	CcSEcCtD
Phentolamine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00222	0.00331	CcSEcCtD
Phentolamine—Paraesthesia—Triamcinolone—multiple sclerosis	0.00219	0.00328	CcSEcCtD
Phentolamine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00219	0.00327	CcSEcCtD
Phentolamine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00217	0.00325	CcSEcCtD
Phentolamine—Nervous system disorder—Betamethasone—multiple sclerosis	0.00217	0.00325	CcSEcCtD
Phentolamine—Tachycardia—Dexamethasone—multiple sclerosis	0.00216	0.00323	CcSEcCtD
Phentolamine—Tachycardia—Betamethasone—multiple sclerosis	0.00216	0.00323	CcSEcCtD
Phentolamine—ADRA2A—medulla oblongata—multiple sclerosis	0.00215	0.0202	CbGeAlD
Phentolamine—ADRA1A—nervous system—multiple sclerosis	0.00213	0.0199	CbGeAlD
Phentolamine—Cardiac disorder—Methotrexate—multiple sclerosis	0.00211	0.00315	CcSEcCtD
Phentolamine—Pain—Triamcinolone—multiple sclerosis	0.00209	0.00312	CcSEcCtD
Phentolamine—Hypotension—Betamethasone—multiple sclerosis	0.00207	0.00309	CcSEcCtD
Phentolamine—Hypotension—Dexamethasone—multiple sclerosis	0.00207	0.00309	CcSEcCtD
Phentolamine—Angiopathy—Methotrexate—multiple sclerosis	0.00206	0.00308	CcSEcCtD
Phentolamine—Vomiting—Mitoxantrone—multiple sclerosis	0.00206	0.00308	CcSEcCtD
Phentolamine—ADRA1A—central nervous system—multiple sclerosis	0.00205	0.0192	CbGeAlD
Phentolamine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.00205	0.00306	CcSEcCtD
Phentolamine—Hypertension—Prednisone—multiple sclerosis	0.00204	0.00305	CcSEcCtD
Phentolamine—Headache—Mitoxantrone—multiple sclerosis	0.00203	0.00303	CcSEcCtD
Phentolamine—ADRA2C—nervous system—multiple sclerosis	0.00203	0.019	CbGeAlD
Phentolamine—ADRA1A—cerebellum—multiple sclerosis	0.002	0.0188	CbGeAlD
Phentolamine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00199	0.00298	CcSEcCtD
Phentolamine—Paraesthesia—Dexamethasone—multiple sclerosis	0.00199	0.00297	CcSEcCtD
Phentolamine—Paraesthesia—Betamethasone—multiple sclerosis	0.00199	0.00297	CcSEcCtD
Phentolamine—SIGMAR1—brain—multiple sclerosis	0.00197	0.0185	CbGeAlD
Phentolamine—ADRA2A—midbrain—multiple sclerosis	0.00197	0.0184	CbGeAlD
Phentolamine—ADRA2C—central nervous system—multiple sclerosis	0.00195	0.0183	CbGeAlD
Phentolamine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00193	0.00288	CcSEcCtD
Phentolamine—Nausea—Mitoxantrone—multiple sclerosis	0.00192	0.00287	CcSEcCtD
Phentolamine—ADRA2A—spinal cord—multiple sclerosis	0.00192	0.018	CbGeAlD
Phentolamine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00191	0.00286	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00191	0.00286	CcSEcCtD
Phentolamine—ADRA2C—cerebellum—multiple sclerosis	0.00191	0.0179	CbGeAlD
Phentolamine—Pain—Betamethasone—multiple sclerosis	0.0019	0.00283	CcSEcCtD
Phentolamine—Pain—Dexamethasone—multiple sclerosis	0.0019	0.00283	CcSEcCtD
Phentolamine—Nervous system disorder—Prednisone—multiple sclerosis	0.00189	0.00283	CcSEcCtD
Phentolamine—Tachycardia—Prednisone—multiple sclerosis	0.00188	0.00281	CcSEcCtD
Phentolamine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00181	0.00271	CcSEcCtD
Phentolamine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00181	0.00271	CcSEcCtD
Phentolamine—Dizziness—Prednisolone—multiple sclerosis	0.00176	0.00262	CcSEcCtD
Phentolamine—Asthenia—Triamcinolone—multiple sclerosis	0.00175	0.00262	CcSEcCtD
Phentolamine—Abdominal pain—Betamethasone—multiple sclerosis	0.00175	0.00262	CcSEcCtD
Phentolamine—Abdominal pain—Dexamethasone—multiple sclerosis	0.00175	0.00262	CcSEcCtD
Phentolamine—Asthenia—Methylprednisolone—multiple sclerosis	0.00175	0.00261	CcSEcCtD
Phentolamine—Paraesthesia—Prednisone—multiple sclerosis	0.00173	0.00259	CcSEcCtD
Phentolamine—Pruritus—Triamcinolone—multiple sclerosis	0.00173	0.00258	CcSEcCtD
Phentolamine—Pruritus—Methylprednisolone—multiple sclerosis	0.00173	0.00258	CcSEcCtD
Phentolamine—Chest pain—Methotrexate—multiple sclerosis	0.00168	0.00251	CcSEcCtD
Phentolamine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00167	0.00249	CcSEcCtD
Phentolamine—Headache—Prednisolone—multiple sclerosis	0.00166	0.00249	CcSEcCtD
Phentolamine—ADRA1A—brain—multiple sclerosis	0.00163	0.0152	CbGeAlD
Phentolamine—ADRA2A—nervous system—multiple sclerosis	0.00162	0.0152	CbGeAlD
Phentolamine—Dizziness—Triamcinolone—multiple sclerosis	0.00162	0.00241	CcSEcCtD
Phentolamine—Dizziness—Methylprednisolone—multiple sclerosis	0.00161	0.00241	CcSEcCtD
Phentolamine—Asthenia—Dexamethasone—multiple sclerosis	0.00159	0.00238	CcSEcCtD
Phentolamine—Asthenia—Betamethasone—multiple sclerosis	0.00159	0.00238	CcSEcCtD
Phentolamine—Nervous system disorder—Methotrexate—multiple sclerosis	0.00158	0.00236	CcSEcCtD
Phentolamine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00158	0.00236	CcSEcCtD
Phentolamine—Nausea—Prednisolone—multiple sclerosis	0.00158	0.00236	CcSEcCtD
Phentolamine—Pruritus—Betamethasone—multiple sclerosis	0.00157	0.00234	CcSEcCtD
Phentolamine—Pruritus—Dexamethasone—multiple sclerosis	0.00157	0.00234	CcSEcCtD
Phentolamine—ADRA2A—central nervous system—multiple sclerosis	0.00156	0.0146	CbGeAlD
Phentolamine—Vomiting—Triamcinolone—multiple sclerosis	0.00155	0.00232	CcSEcCtD
Phentolamine—Vomiting—Methylprednisolone—multiple sclerosis	0.00155	0.00232	CcSEcCtD
Phentolamine—ADRA2C—brain—multiple sclerosis	0.00155	0.0145	CbGeAlD
Phentolamine—Headache—Triamcinolone—multiple sclerosis	0.00153	0.00229	CcSEcCtD
Phentolamine—Headache—Methylprednisolone—multiple sclerosis	0.00153	0.00228	CcSEcCtD
Phentolamine—Abdominal pain—Prednisone—multiple sclerosis	0.00153	0.00228	CcSEcCtD
Phentolamine—ADRA2A—cerebellum—multiple sclerosis	0.00152	0.0143	CbGeAlD
Phentolamine—Diarrhoea—Dexamethasone—multiple sclerosis	0.00152	0.00227	CcSEcCtD
Phentolamine—Diarrhoea—Betamethasone—multiple sclerosis	0.00152	0.00227	CcSEcCtD
Phentolamine—Hypotension—Methotrexate—multiple sclerosis	0.00151	0.00225	CcSEcCtD
Phentolamine—Dizziness—Betamethasone—multiple sclerosis	0.00147	0.00219	CcSEcCtD
Phentolamine—Dizziness—Dexamethasone—multiple sclerosis	0.00147	0.00219	CcSEcCtD
Phentolamine—Nausea—Triamcinolone—multiple sclerosis	0.00145	0.00217	CcSEcCtD
Phentolamine—Paraesthesia—Methotrexate—multiple sclerosis	0.00145	0.00216	CcSEcCtD
Phentolamine—Nausea—Methylprednisolone—multiple sclerosis	0.00145	0.00216	CcSEcCtD
Phentolamine—Vomiting—Betamethasone—multiple sclerosis	0.00141	0.00211	CcSEcCtD
Phentolamine—Vomiting—Dexamethasone—multiple sclerosis	0.00141	0.00211	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00139	0.00208	CcSEcCtD
Phentolamine—Headache—Betamethasone—multiple sclerosis	0.00139	0.00207	CcSEcCtD
Phentolamine—Headache—Dexamethasone—multiple sclerosis	0.00139	0.00207	CcSEcCtD
Phentolamine—Asthenia—Prednisone—multiple sclerosis	0.00139	0.00207	CcSEcCtD
Phentolamine—Pain—Methotrexate—multiple sclerosis	0.00138	0.00206	CcSEcCtD
Phentolamine—Pruritus—Prednisone—multiple sclerosis	0.00137	0.00204	CcSEcCtD
Phentolamine—Diarrhoea—Prednisone—multiple sclerosis	0.00132	0.00197	CcSEcCtD
Phentolamine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.00132	0.00197	CcSEcCtD
Phentolamine—Nausea—Betamethasone—multiple sclerosis	0.00132	0.00197	CcSEcCtD
Phentolamine—Nausea—Dexamethasone—multiple sclerosis	0.00132	0.00197	CcSEcCtD
Phentolamine—Dizziness—Prednisone—multiple sclerosis	0.00128	0.00191	CcSEcCtD
Phentolamine—Abdominal pain—Methotrexate—multiple sclerosis	0.00128	0.00191	CcSEcCtD
Phentolamine—ADRA2A—brain—multiple sclerosis	0.00124	0.0116	CbGeAlD
Phentolamine—Vomiting—Prednisone—multiple sclerosis	0.00123	0.00183	CcSEcCtD
Phentolamine—Headache—Prednisone—multiple sclerosis	0.00121	0.00181	CcSEcCtD
Phentolamine—Asthenia—Methotrexate—multiple sclerosis	0.00116	0.00173	CcSEcCtD
Phentolamine—Nausea—Prednisone—multiple sclerosis	0.00115	0.00171	CcSEcCtD
Phentolamine—Pruritus—Methotrexate—multiple sclerosis	0.00114	0.00171	CcSEcCtD
Phentolamine—Diarrhoea—Methotrexate—multiple sclerosis	0.0011	0.00165	CcSEcCtD
Phentolamine—Dizziness—Methotrexate—multiple sclerosis	0.00107	0.00159	CcSEcCtD
Phentolamine—Vomiting—Methotrexate—multiple sclerosis	0.00103	0.00153	CcSEcCtD
Phentolamine—Headache—Methotrexate—multiple sclerosis	0.00101	0.00151	CcSEcCtD
Phentolamine—Nausea—Methotrexate—multiple sclerosis	0.000959	0.00143	CcSEcCtD
Phentolamine—ADRA2B—GPCR downstream signaling—CCR5—multiple sclerosis	0.000133	0.000594	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—IL2RA—multiple sclerosis	0.000132	0.000589	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CNR1—multiple sclerosis	0.000131	0.000586	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000131	0.000585	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PTGER4—multiple sclerosis	0.00013	0.000583	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CXCL13—multiple sclerosis	0.00013	0.000582	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCR1—multiple sclerosis	0.00013	0.000582	CbGpPWpGaD
Phentolamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.00013	0.000582	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00013	0.000581	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PGR—multiple sclerosis	0.000128	0.000574	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000127	0.000568	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CXCR3—multiple sclerosis	0.000126	0.000563	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—CCL5—multiple sclerosis	0.000125	0.000559	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CD28—multiple sclerosis	0.000125	0.000557	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—CCR5—multiple sclerosis	0.000124	0.000555	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CCL5—multiple sclerosis	0.000123	0.00055	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CCR2—multiple sclerosis	0.000122	0.000547	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000122	0.000547	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCL3—multiple sclerosis	0.000122	0.000546	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—CCR5—multiple sclerosis	0.000122	0.000546	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—IL2—multiple sclerosis	0.000121	0.000543	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—CCR5—multiple sclerosis	0.000121	0.000539	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—CCL5—multiple sclerosis	0.00012	0.000538	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—BCHE—multiple sclerosis	0.00012	0.000538	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—IL2RA—multiple sclerosis	0.00012	0.000538	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL2RA—multiple sclerosis	0.000119	0.000531	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000118	0.000527	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PTGER4—multiple sclerosis	0.000118	0.000526	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PGR—multiple sclerosis	0.000116	0.000518	CbGpPWpGaD
Phentolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000116	0.000517	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—POMC—multiple sclerosis	0.000115	0.000514	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCL3—multiple sclerosis	0.000114	0.00051	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CXCR3—multiple sclerosis	0.000114	0.000508	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—ALB—multiple sclerosis	0.000114	0.000508	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—IL2—multiple sclerosis	0.000113	0.000507	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CNR1—multiple sclerosis	0.000113	0.000505	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—CCR5—multiple sclerosis	0.000113	0.000504	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CD28—multiple sclerosis	0.000113	0.000503	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCL3—multiple sclerosis	0.000112	0.000502	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CCL5—multiple sclerosis	0.000112	0.0005	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL2RA—multiple sclerosis	0.000111	0.000496	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CCR5—multiple sclerosis	0.000111	0.000496	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCR2—multiple sclerosis	0.000111	0.000494	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PTGER4—multiple sclerosis	0.00011	0.000491	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	0.000109	0.000489	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL2RA—multiple sclerosis	0.000109	0.000488	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	0.000108	0.000485	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PGR—multiple sclerosis	0.000108	0.000484	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PTGER4—multiple sclerosis	0.000108	0.000484	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000107	0.000478	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PGR—multiple sclerosis	0.000107	0.000476	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CXCR3—multiple sclerosis	0.000106	0.000475	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CD28—multiple sclerosis	0.000105	0.00047	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CXCR3—multiple sclerosis	0.000104	0.000467	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—POMC—multiple sclerosis	0.000104	0.000467	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—POMC—multiple sclerosis	0.000104	0.000464	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CD28—multiple sclerosis	0.000103	0.000463	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCR2—multiple sclerosis	0.000103	0.000462	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—CCL2—multiple sclerosis	0.000102	0.000457	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CNR1—multiple sclerosis	0.000102	0.000456	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CXCL10—multiple sclerosis	0.000102	0.000455	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCR2—multiple sclerosis	0.000102	0.000454	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CCL5—multiple sclerosis	0.000102	0.000454	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CCR5—multiple sclerosis	0.000101	0.00045	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	9.98e-05	0.000446	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	9.93e-05	0.000444	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	9.85e-05	0.00044	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—BCHE—multiple sclerosis	9.77e-05	0.000437	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	9.7e-05	0.000434	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—POMC—multiple sclerosis	9.69e-05	0.000433	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	9.61e-05	0.00043	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—POMC—multiple sclerosis	9.54e-05	0.000427	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CNR1—multiple sclerosis	9.53e-05	0.000426	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—TGFB1—multiple sclerosis	9.47e-05	0.000423	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	9.46e-05	0.000423	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—POMC—multiple sclerosis	9.42e-05	0.000421	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CNR1—multiple sclerosis	9.38e-05	0.000419	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—MAPK1—multiple sclerosis	9.29e-05	0.000415	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	9.28e-05	0.000415	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—TYK2—multiple sclerosis	9.27e-05	0.000415	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCL3—multiple sclerosis	9.27e-05	0.000415	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—CCL2—multiple sclerosis	9.22e-05	0.000412	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—IL2—multiple sclerosis	9.21e-05	0.000412	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	9.19e-05	0.000411	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CXCL10—multiple sclerosis	9.19e-05	0.000411	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CCR5—multiple sclerosis	9.15e-05	0.000409	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	9.03e-05	0.000404	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL2RA—multiple sclerosis	9.02e-05	0.000403	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PTGER4—multiple sclerosis	8.93e-05	0.000399	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CD86—multiple sclerosis	8.9e-05	0.000398	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—TGFB1—multiple sclerosis	8.85e-05	0.000395	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—POMC—multiple sclerosis	8.8e-05	0.000394	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	8.79e-05	0.000393	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CCL5—multiple sclerosis	8.76e-05	0.000392	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—MAPK1—multiple sclerosis	8.67e-05	0.000388	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—POMC—multiple sclerosis	8.66e-05	0.000387	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	8.62e-05	0.000385	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—CCL2—multiple sclerosis	8.61e-05	0.000385	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CXCL10—multiple sclerosis	8.58e-05	0.000384	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	8.54e-05	0.000382	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—IL2—multiple sclerosis	8.5e-05	0.00038	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CCL2—multiple sclerosis	8.48e-05	0.000379	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	8.47e-05	0.000379	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CXCL10—multiple sclerosis	8.44e-05	0.000378	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	8.39e-05	0.000375	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—TYK2—multiple sclerosis	8.37e-05	0.000374	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	8.33e-05	0.000372	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—SPP1—multiple sclerosis	8.11e-05	0.000363	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CD86—multiple sclerosis	8.03e-05	0.000359	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCL5—multiple sclerosis	7.91e-05	0.000353	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CCR5—multiple sclerosis	7.89e-05	0.000353	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	7.87e-05	0.000352	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—TYK2—multiple sclerosis	7.82e-05	0.00035	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL2RA—multiple sclerosis	7.78e-05	0.000348	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	7.74e-05	0.000346	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—IL2—multiple sclerosis	7.72e-05	0.000345	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—TYK2—multiple sclerosis	7.7e-05	0.000344	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	7.7e-05	0.000344	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—IL2—multiple sclerosis	7.67e-05	0.000343	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	7.53e-05	0.000337	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CD86—multiple sclerosis	7.5e-05	0.000335	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	7.5e-05	0.000335	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCL5—multiple sclerosis	7.39e-05	0.00033	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CD86—multiple sclerosis	7.38e-05	0.00033	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—SPP1—multiple sclerosis	7.32e-05	0.000327	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCL5—multiple sclerosis	7.27e-05	0.000325	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—APOE—multiple sclerosis	7.24e-05	0.000324	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	7.18e-05	0.000321	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—APOE—multiple sclerosis	7.18e-05	0.000321	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—IL2—multiple sclerosis	7.17e-05	0.00032	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	7.15e-05	0.00032	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	7.12e-05	0.000318	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	7.05e-05	0.000315	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	7.05e-05	0.000315	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	7.02e-05	0.000314	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	7e-05	0.000313	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	6.97e-05	0.000312	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	6.97e-05	0.000311	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—SPP1—multiple sclerosis	6.84e-05	0.000306	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	6.84e-05	0.000306	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	6.73e-05	0.000301	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCR5—multiple sclerosis	6.65e-05	0.000297	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	6.56e-05	0.000293	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL2RA—multiple sclerosis	6.56e-05	0.000293	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	6.55e-05	0.000293	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL2—multiple sclerosis	6.51e-05	0.000291	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CD80—multiple sclerosis	6.49e-05	0.00029	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	6.48e-05	0.00029	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	6.46e-05	0.000289	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	6.45e-05	0.000289	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	6.4e-05	0.000286	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	6.35e-05	0.000284	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	6.26e-05	0.00028	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—POMC—multiple sclerosis	6.22e-05	0.000278	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—POMC—multiple sclerosis	6.17e-05	0.000276	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	6.09e-05	0.000272	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—APOE—multiple sclerosis	6.05e-05	0.000271	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CCL2—multiple sclerosis	6.03e-05	0.00027	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	6e-05	0.000268	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	5.98e-05	0.000267	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	5.96e-05	0.000266	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—MAPK1—multiple sclerosis	5.9e-05	0.000264	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—APOE—multiple sclerosis	5.88e-05	0.000263	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	5.86e-05	0.000262	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	5.82e-05	0.00026	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	5.82e-05	0.00026	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	5.73e-05	0.000256	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	5.69e-05	0.000254	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—ALB—multiple sclerosis	5.67e-05	0.000253	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	5.57e-05	0.000249	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	5.56e-05	0.000248	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	5.48e-05	0.000245	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	5.47e-05	0.000245	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	5.45e-05	0.000244	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	5.4e-05	0.000242	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	5.39e-05	0.000241	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	5.33e-05	0.000238	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	5.33e-05	0.000238	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	5.29e-05	0.000237	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	5.29e-05	0.000236	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	5.2e-05	0.000232	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	5.12e-05	0.000229	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	5.09e-05	0.000227	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—POMC—multiple sclerosis	5.05e-05	0.000226	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	5.01e-05	0.000224	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	4.98e-05	0.000223	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	4.95e-05	0.000221	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	4.92e-05	0.00022	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	4.9e-05	0.000219	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	4.78e-05	0.000214	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	4.62e-05	0.000207	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ALB—multiple sclerosis	4.61e-05	0.000206	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	4.56e-05	0.000204	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	4.55e-05	0.000203	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	4.55e-05	0.000203	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	4.54e-05	0.000203	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	4.45e-05	0.000199	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	4.45e-05	0.000199	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	4.35e-05	0.000195	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	4.31e-05	0.000193	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	4.22e-05	0.000189	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	4.13e-05	0.000185	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	4.12e-05	0.000184	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	4.1e-05	0.000183	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	4.04e-05	0.000181	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	4.04e-05	0.000181	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	3.9e-05	0.000174	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	3.84e-05	0.000172	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	3.84e-05	0.000172	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	3.83e-05	0.000171	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	3.78e-05	0.000169	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	3.76e-05	0.000168	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	3.75e-05	0.000168	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	3.64e-05	0.000163	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	3.58e-05	0.00016	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	3.56e-05	0.000159	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	3.56e-05	0.000159	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	3.49e-05	0.000156	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	3.46e-05	0.000155	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	3.36e-05	0.00015	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	3.34e-05	0.00015	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	3.24e-05	0.000145	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	3.22e-05	0.000144	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	3.21e-05	0.000144	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	3.18e-05	0.000142	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	3.18e-05	0.000142	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	3.15e-05	0.000141	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	3.12e-05	0.00014	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	3.11e-05	0.000139	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	3.01e-05	0.000134	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	3e-05	0.000134	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	2.96e-05	0.000132	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	2.96e-05	0.000132	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	2.95e-05	0.000132	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	2.94e-05	0.000131	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	2.89e-05	0.000129	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	2.83e-05	0.000126	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	2.68e-05	0.00012	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	2.63e-05	0.000117	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	2.63e-05	0.000117	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	2.62e-05	0.000117	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	2.57e-05	0.000115	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	2.44e-05	0.000109	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	2.44e-05	0.000109	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	2.42e-05	0.000108	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	2.39e-05	0.000107	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	2.26e-05	0.000101	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	2.22e-05	9.94e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	1.98e-05	8.83e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	1.84e-05	8.21e-05	CbGpPWpGaD
